Colin J Carati Selected Research

galantide (M 15)

8/2010	Octreotide negates the benefit of galantide when used in the treatment of caerulein-induced acute pancreatitis in mice.
6/2010	The efficacy of combining feG and galantide in mild caerulein-induced acute pancreatitis in mice.
3/2010	Galanin mediates the pathogenesis of cerulein-induced acute pancreatitis in the mouse.
2/2010	The combination of neurokinin-1 and galanin receptor antagonists ameliorates caerulein-induced acute pancreatitis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Colin J Carati Research Topics

Disease

5	Pancreatitis 08/2010 - 04/2008
2	Necrosis 03/2010 - 02/2010
1	Contracture 01/2017
1	Neurogenic Inflammation 06/2010
1	Hyperamylasemia 02/2010
1	Ileitis 10/2006
1	Inflammation (Inflammations) 10/2006
1	Breast Cancer Lymphedema 09/2003

Drug/Important Bio-Agent (IBA)

5	CeruletideIBA 08/2010 - 04/2008
4	galantide (M 15)IBA 08/2010 - 02/2010
2	Galanin Receptors (Galanin Receptor)IBA 08/2010 - 02/2010
2	GalaninIBA 03/2010 - 02/2010
1	Capsules (Microcapsules)IBA 01/2017
1	SiliconesIBA 01/2017
1	Octreotide (Sandostatin)FDA LinkGeneric 08/2010
1	Peptides (Polypeptides)IBA 06/2010
1	Amylases FDA Link 03/2010
1	Lipase (Acid Lipase)FDA Link 03/2010
1	Peroxidase (Myeloperoxidase)IBA 03/2010
1	Neurokinin-1 Receptor AntagonistsIBA 02/2010
1	Substance PIBA 02/2010
1	salicylhydroxamic acid (SHAM)IBA 10/2006
1	ProstaglandinsIBA 10/2006
1	AcidsIBA 10/2006

Therapy/Procedure

2	Injections 08/2010 - 02/2010
1	Breast Implants (Breast Implant) 01/2017
1	Intraperitoneal Injections 03/2010
1	Lasers (Laser) 09/2003
1	Aftercare (After-Treatment) 09/2003
1	Low-Level Light Therapy (LLLT) 09/2003